COMMUNIQUÉS West-GlobeNewswire

BioCryst's BCX7353 Receives European Regulatory Designations for the Treatment of Hereditary Angioedema

24/05/2018 - 18:30

EMA Grants Orphan Designation UK MHRA Grants Promising Innovative Medicine Designation RESEARCH TRIANGLE PARK, N.C., May 24, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ), a pharmaceutical [...]

BIOPHYTIS: Inclusion of the First Patient in Phase 2b Study in Sarcopenia

24/05/2018 - 18:00

Preliminary results expected in Q3 2019 PARIS, May 24, 2018 (GLOBE NEWSWIRE) -- BIOPHYTIS (Euronext Growth Paris: ALBPS), a biotechnology company specializing in the development of drug candidates to fight age-related [...]

Bulletin from the Annual Shareholders’ Meeting on May 24, 2018 in Saniona AB (Publ)

24/05/2018 - 17:30

PRESS RELEASE May 24, 2018 Today, on May 24, 2018, an annual shareholders’ meeting was held in Saniona AB (publ). A summary of the resolutions adopted follows below. All resolutions were adopted with the required [...]

Initial Clinical Results of Konica Minolta Healthcare’s Dynamic Digital Radiography Presented at ATS 2018 Annual Meeting

24/05/2018 - 16:32

WAYNE, N.J., May 24, 2018 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc., announced that two clinical studies utilizing Dynamic Digital Radiography (DDR), the company’s innovative X-ray technology under [...]

Genmab Announces Topline Results in Phase III study of Arzerra® in Indolent Non-Hodgkin’s Lymphoma

24/05/2018 - 16:20

Company Announcement Topline results from Phase III study in iNHL did not meet primary endpoint of improved progression-free survival Copenhagen, Denmark; May 24, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) announced [...]

Tabula Rasa HealthCare to Participate in Upcoming Investor Conferences

24/05/2018 - 16:00

MOORESTOWN, N.J., May 24, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC ), a healthcare technology company optimizing medication safety by deploying new, medication risk mitigation [...]

Abattis and Vergence Naturals Launch New Marketing Campaign

24/05/2018 - 15:12

VANCOUVER, British Columbia, May 24, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp . (the " Company " or " Abattis ") (CSE:ATT) (OTC:ATTBF) and its wholly-owned subsidiary, Vergence Naturals Ltd. (“ Vergence ”), [...]

Notification on convocation of joint stock company “GRINDEKS” Annual General Meeting of shareholders

24/05/2018 - 15:10

The Management Board of joint stock company “Grindeks” (registration number: 40003034935, legal address: 53 Krustpils street, Riga, Latvia, LV-1057) calls up and announces that Annual General Meeting of Shareholders of [...]

Adamas Announces Publication of Pharmacokinetic Data for GOCOVRI™ in Clinical Pharmacokinetics

24/05/2018 - 15:05

EMERYVILLE, Calif., May 24, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that pharmacokinetic (PK) data regarding GOCOVRI™ (amantadine) extended release capsules were published [...]

OrthoPediatrics Corp. to Present at Jefferies & William Blair Healthcare Conferences

24/05/2018 - 15:00

WARSAW, Ind., May 24, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS ), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that Mark Throdahl [...]

Ceapro Inc. to Provide a Corporate Update at Its Annual General and Special Meeting of Shareholders on May 29, 2018

24/05/2018 - 15:00

EDMONTON, Alberta, May 24, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO ) (“Ceapro” or the “Company”) , a growth-stage biotechnology company focused on the development and commercialization of active ingredients for [...]

Prothena Announces Reorganization to Focus Resources on Advancing Neuroscience Pipeline

24/05/2018 - 15:00

DUBLIN, Ireland, May 24, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ: PRTA ), a clinical-stage biotechnology company focused on the discovery and development of novel therapies in the neuroscience category [...]

Fibrocell Announces One-for-Five Reverse Stock Split

24/05/2018 - 14:56

Shares of Common Stock Will Begin Trading on Split-Adjusted Basis on May 25, 2018 EXTON, Pa., May 24, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC ), a gene therapy company focused on transformational [...]

Maximize Your Garden Time By Weeding Out Aches and Pains With Arnicare

24/05/2018 - 14:34

NEWTOWN SQUARE, Pa., May 24, 2018 (GLOBE NEWSWIRE) -- Even pleasant pastimes can be painful. Gardening is one of many seasonal activities that can be enjoyable, but can also lead to muscle soreness and pain. Recent [...]

Marrone Bio Innovations Expands Sales Team and Establishes New Sales Territory

24/05/2018 - 14:31

DAVIS, Calif., May 24, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (“MBI” or the “Company”) (NASDAQ: MBII ), a leading provider of bio-based pest management and plant health products for the agriculture, turf [...]

The University of New Brunswick signs MOU with Canada House Wellness Group

24/05/2018 - 14:30

FREDERICTON, New Brunswick , May 24, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) is pleased to announce that it has signed a Memorandum of Understanding (MOU) [...]

Clinical Genomics Presents Clinical Utility Data for COLVERA™ at 2018 ASCO Annual Meeting

24/05/2018 - 14:30

BRIDGEWATER, N.J., May 24, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of colorectal cancer (CRC) testing and solutions, today announced that data demonstrating the utility of COLVERA for detection of [...]

Moleculin Invited to Present to International BioForum 2018 Conference

24/05/2018 - 14:30

HOUSTON, May 24, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX ) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]

Portola Pharmaceuticals Receives $100 Million Milestone Payment from HealthCare Royalty Partners for FDA Approval of Andexxa®

24/05/2018 - 14:30

SOUTH SAN FRANCISCO, Calif., May 24, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA ) today announced that the company has received a $100 million milestone payment from HealthCare Royalty [...]